Registered entities
Aligos Therapeutics, Inc.
Reg. No. 82-4724808United States
Innovation
72 patent families (30 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady.
Social engagement
Social engagement: 7.5K social following, 9 posts in the last 12 months — below the industry typical range.
Recent activity
3 Jun 2026
Event
EASL | The Home of Hepatology Congress 2026
27 May 2026
Event
EASL Congress 2026
14 May 2026
Event
33rd European Congress on Obesity